%0 Journal Article
%T Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy
%A Malapelle, Umberto
%A Iaccarino, Antonino
%A Rossi, Antonio
%J Translational Lung Cancer Research
%D 2018
%B 2018
%9 
%! Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy
%K 
%X Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) represent key targets for specific monoclonal antibody inhibitors, such as pembrolizumab, nivolumab and atezolizumab, currently used in clinical practice for the management of metastatic non-small cell lung cancer (NSCLC) patients (1).
%U https://tlcr.amegroups.org/article/view/23598
%P S221-S224
%@ 2226-4477